Conference Proceedings

ELEVATED THYROID STIMULATING HORMONE AS A POTENTIAL BIOMARKER FOR RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FOLLOWING PD-1 INHIBITOR THERAPY

DFL Liew, JLY Leung, C McMaster, F Djukiadmodjo, B Liu, J Cebon, AG Frauman, RRC Buchanan

ANNALS OF THE RHEUMATIC DISEASES | BMJ PUBLISHING GROUP | Published : 2018